Anti-Osteoporotic Mechanisms of Polyphenols Elucidated Based on In Vivo Studies Using Ovariectomized Animals

Area of Science:

• Pharmacology
• Biochemistry
• Bone Biology

Background:

• Postmenopausal osteoporosis is linked to estrogen deficiency and oxidative stress.
• Oxidative stress is a key factor in osteoporosis development and progression.
• Polyphenols possess antioxidant properties that may counteract oxidative stress.

Purpose of the Study:

• To review in vivo studies on ovariectomized animals.
• To elucidate the anti-osteoporotic mechanisms of polyphenols.
• To categorize polyphenols as resveratrol, purified compounds, or extracts.

Main Methods:

• Literature review of in vivo studies using ovariectomized animal models.
• Categorization of polyphenols into resveratrol, other purified polyphenols, and polyphenol-rich substances.
• Analysis of molecular pathways involved in bone remodeling.

Main Results:

• Resveratrol activates sirtuin 1, suppressing osteoclastogenesis (RANKL pathway) and promoting osteoblastogenesis (Wnt pathway).
• Other purified polyphenols and extracts show anti-inflammatory and antioxidative effects.
• These compounds inhibit RANKL/RANK binding via the NF-κB pathway, reducing osteoclast formation.

Conclusions:

• Antioxidative and anti-inflammatory polyphenols, including resveratrol, show potential as safe treatments for postmenopausal osteoporosis.
• Polyphenols effectively regulate the balance between bone formation and resorption.
• These mechanisms target key pathways involved in osteoporosis pathogenesis.